Equillium Stock Alpha and Beta Analysis
| EQ Stock | USD 0.94 0.23 32.39% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Equillium. It also helps investors analyze the systematic and unsystematic risks associated with investing in Equillium over a specified time horizon. Remember, high Equillium's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Equillium's market risk premium analysis include:
Beta (0.42) | Alpha 0.34 | Risk 6.36 | Sharpe Ratio 0.0893 | Expected Return 0.57 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Equillium |
Equillium Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Equillium market risk premium is the additional return an investor will receive from holding Equillium long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Equillium. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Equillium's performance over market.| α | 0.34 | β | -0.42 |
Equillium expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Equillium's Buy-and-hold return. Our buy-and-hold chart shows how Equillium performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Equillium Market Price Analysis
Market price analysis indicators help investors to evaluate how Equillium stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Equillium shares will generate the highest return on investment. By understating and applying Equillium stock market price indicators, traders can identify Equillium position entry and exit signals to maximize returns.
Equillium Return and Market Media
The median price of Equillium for the period between Sat, Nov 9, 2024 and Fri, Feb 7, 2025 is 0.7 with a coefficient of variation of 8.77. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 0.71, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer | 11/12/2024 |
2 | Equillium to Present at the Stifel Healthcare Conference | 11/13/2024 |
3 | Disposition of 10000 shares by Jason Keyes of Equillium at 0.7 subject to Rule 16b-3 | 11/14/2024 |
4 | Acquisition by Daniel Bradbury of 38000 shares of Equillium at 3.59 subject to Rule 16b-3 | 12/06/2024 |
5 | Insider Trading | 12/11/2024 |
6 | Acquisition by Colabuono Peter of 40000 shares of Equillium at 0.7 subject to Rule 16b-3 | 12/12/2024 |
7 | EQ Europe New KPI - A Game Changer for Level21 | 12/13/2024 |
8 | Acquisition by Penny Tom of 125000 shares of Equillium at 0.77 subject to Rule 16b-3 | 01/06/2025 |
9 | SI EQ Rebrands to RootBeta with Expanded Team and Expanded Ag Industry Focus | 01/08/2025 |
10 | EQ recognized as 4 Top Employer in the U.S. by the Top Employer Institute | 01/16/2025 |
11 | Disposition of 10000 shares by Jason Keyes of Equillium at 0.65 subject to Rule 16b-3 | 01/23/2025 |
12 | Equillium Braces For Two Key Clinical Trial Data Readouts - Will The Stock Get A Boost - RTTNews | 01/30/2025 |
13 | Equillium Reports Positive Phase 2 Results for Itolizumab in Ulcerative Colitis, Shares Surge | 02/06/2025 |
About Equillium Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Equillium or other stocks. Alpha measures the amount that position in Equillium has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 (projected) | Graham Number | 2.37 | 2.73 | 2.59 | Receivables Turnover | 5.74 | 5.17 | 4.52 |
Equillium Upcoming Company Events
As portrayed in its financial statements, the presentation of Equillium's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Equillium's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Equillium's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Equillium. Please utilize our Beneish M Score to check the likelihood of Equillium's management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Equillium
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Equillium Stock Analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.